These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Butyrate: A Double-Edged Sword for Health? Liu H; Wang J; He T; Becker S; Zhang G; Li D; Ma X Adv Nutr; 2018 Jan; 9(1):21-29. PubMed ID: 29438462 [TBL] [Abstract][Full Text] [Related]
3. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Sivaprakasam S; Prasad PD; Singh N Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407 [TBL] [Abstract][Full Text] [Related]
4. Dietary resistant starch and chronic inflammatory bowel diseases. Jacobasch G; Schmiedl D; Kruschewski M; Schmehl K Int J Colorectal Dis; 1999 Nov; 14(4-5):201-11. PubMed ID: 10647628 [TBL] [Abstract][Full Text] [Related]
5. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease. Gonçalves P; Araújo JR; Di Santo JP Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379 [TBL] [Abstract][Full Text] [Related]
6. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343 [TBL] [Abstract][Full Text] [Related]
7. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease. Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831 [TBL] [Abstract][Full Text] [Related]
8. Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation. Bach Knudsen KE; Lærke HN; Hedemann MS; Nielsen TS; Ingerslev AK; Gundelund Nielsen DS; Theil PK; Purup S; Hald S; Schioldan AG; Marco ML; Gregersen S; Hermansen K Nutrients; 2018 Oct; 10(10):. PubMed ID: 30322146 [TBL] [Abstract][Full Text] [Related]
9. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. Sun M; Wu W; Liu Z; Cong Y J Gastroenterol; 2017 Jan; 52(1):1-8. PubMed ID: 27448578 [TBL] [Abstract][Full Text] [Related]
10. [Effect of dietary fiber in the quantitative expression of butyrate receptor GPR43 in rats colon]. Corte Osorio LY; Martínez Flores HE; Ortiz Alvarado R Nutr Hosp; 2011; 26(5):1052-8. PubMed ID: 22072352 [TBL] [Abstract][Full Text] [Related]
11. Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases. Gasaly N; Hermoso MA; Gotteland M Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802759 [TBL] [Abstract][Full Text] [Related]
12. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA Front Immunol; 2019; 10():277. PubMed ID: 30915065 [TBL] [Abstract][Full Text] [Related]
13. Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Bourassa MW; Alim I; Bultman SJ; Ratan RR Neurosci Lett; 2016 Jun; 625():56-63. PubMed ID: 26868600 [TBL] [Abstract][Full Text] [Related]
14. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Li G; Lin J; Zhang C; Gao H; Lu H; Gao X; Zhu R; Li Z; Li M; Liu Z Gut Microbes; 2021; 13(1):1968257. PubMed ID: 34494943 [TBL] [Abstract][Full Text] [Related]
15. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Chen D; Jin D; Huang S; Wu J; Xu M; Liu T; Dong W; Liu X; Wang S; Zhong W; Liu Y; Jiang R; Piao M; Wang B; Cao H Cancer Lett; 2020 Jan; 469():456-467. PubMed ID: 31734354 [TBL] [Abstract][Full Text] [Related]
16. Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease. Hodgkinson K; El Abbar F; Dobranowski P; Manoogian J; Butcher J; Figeys D; Mack D; Stintzi A Clin Nutr; 2023 Feb; 42(2):61-75. PubMed ID: 36502573 [TBL] [Abstract][Full Text] [Related]
17. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease. Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541 [TBL] [Abstract][Full Text] [Related]
18. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Thibault R; Blachier F; Darcy-Vrillon B; de Coppet P; Bourreille A; Segain JP Inflamm Bowel Dis; 2010 Apr; 16(4):684-95. PubMed ID: 19774643 [TBL] [Abstract][Full Text] [Related]
19. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Geirnaert A; Calatayud M; Grootaert C; Laukens D; Devriese S; Smagghe G; De Vos M; Boon N; Van de Wiele T Sci Rep; 2017 Sep; 7(1):11450. PubMed ID: 28904372 [TBL] [Abstract][Full Text] [Related]
20. Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells. Eslami M; Sadrifar S; Karbalaei M; Keikha M; Kobyliak NM; Yousefi B J Gastrointest Cancer; 2020 Sep; 51(3):738-747. PubMed ID: 31735976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]